Rein3DP-M
Phase NA Recruiting
50 enrolled
RCCETT
Recruiting
4,700 enrolled
NEOPAX
Phase 2 Recruiting
17 enrolled
Kidney Cancer DNA Registry
Recruiting
750 enrolled
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Phase 1 Recruiting
35 enrolled
NEPHRAMBU
Recruiting
50 enrolled
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 Recruiting
10 enrolled
PP-RECURK
Recruiting
105 enrolled
ORCHID
Phase 2 Recruiting
20 enrolled
SPARCC
Phase 2 Recruiting
25 enrolled
NAMECAR
Phase NA Recruiting
60 enrolled
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Phase 2 Recruiting
32 enrolled
MetroWilms
Phase 1/2 Recruiting
28 enrolled
64Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/2 Recruiting
91 enrolled
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 Recruiting
148 enrolled
68Ga-PSMA PET in the Renal Cell Carcinoma
Phase NA Recruiting
300 enrolled
DISSRM
Recruiting
600 enrolled
OCCURORTW
Recruiting
2,000 enrolled
VERDI
Phase NA Recruiting
1,020 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
WASHOUT
Recruiting
1,050 enrolled
SMILe
Phase 3 Recruiting
220 enrolled
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Phase NA Recruiting
600 enrolled
COSTAR
Recruiting
300 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
Recruiting
53 enrolled
STROKER
Phase 3 Recruiting
252 enrolled
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Phase 2 Recruiting
40 enrolled
CD70-targeted immunoPET Imaging of Kidney Cancer
Phase 2 Recruiting
300 enrolled
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Recruiting
30 enrolled
TACTICAL1
Phase NA Recruiting
6,272 enrolled
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Phase NA Recruiting
90 enrolled
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Recruiting
450 enrolled
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Recruiting
39 enrolled
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Phase NA Recruiting
220 enrolled
Decision Aid (DA) for Renal Patients
Phase NA Recruiting
40 enrolled
LIBERATE
Recruiting
2,500 enrolled
K3
Phase NA Recruiting
124 enrolled
Immunobiome
Phase NA Recruiting
20 enrolled
Stereotactic Magnetic Resonance Guided Radiation Therapy
Phase NA Recruiting
397 enrolled
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting
2,000 enrolled
CANIQOL
Phase 4 Recruiting
83 enrolled
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Phase 1/2 Recruiting
50 enrolled
CABOLD
Phase 4 Recruiting
50 enrolled
UroCCR
Recruiting
30,000 enrolled
No-PAIN
Phase 2 Recruiting
110 enrolled
Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy
Phase NA Recruiting
190 enrolled
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 Recruiting
400 enrolled